Syndax Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$24.23

+0.23 (+0.96%)

As of Mar 22, 10:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +1.1% upside

Low Target $15.15

Average Target $24.49

High Target $32.88

Current Price $24.23

Current
$24.23

Target
$24.49

$15.15 $24.49 avg $32.88

Scenario Analysis

Bear Case

$15.15

-37.5%

Low target

Base Case

$24.49

+1.1%

Avg target

Bull Case

$32.88

+35.7%

High target

Risk/Reward

1.0x

Unfavorable

Price in Context

52-Week High

$22.73

6.6% from high

52-Week Low

$8.58

+182.4% from low

Target vs 52W High

$24.49

+7.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%